TABLE 1.
Overall | Women under screening age | Women over screening age | All women of screening age | Women of screening age not attending screening | Women of screening age attending screening | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean age in years (range) | 60 | (22–99) | 23 | (22–24) | 80 | (70–99) | 50 | (25–69) | 52 | (25–69) | 45 | (26–68) |
n | % | n | % | n | % | n | % | n | % | n | % | |
All cases | 817 | 100.0 | 7 | 100.0 | 290 | 100.0 | 520 | 100.0 | 382 | 100.0 | 138 | 100.0 |
Last cytology 0.5–3.5 years | 173 | 21.2 | 5 | 71.4 | 30 | 10.3 | 138 | 26.5 | ||||
FIGO stage | ||||||||||||
IA | 7 | 0.7 | 1 | 14.3 | 0 | 0.0 | 6 | 1.2 | 2 | 0.5 | 4 | 2.9 |
IB–IIA | 162 | 29.8 | 3 | 42.9 | 30 | 10.3 | 129 | 24.8 | 75 | 19.6 | 54 | 39.1 |
IIB+ | 621 | 76.0 | 2 | 28.6 | 246 | 84.8 | 373 | 71.7 | 295 | 77.2 | 78 | 56.5 |
Unknown | 27 | 3.3 | 1 | 14.3 | 14 | 4.8 | 12 | 2.3 | 10 | 2.6 | 2 | 1.4 |
Morphology | ||||||||||||
Squamous cell carcinoma | 561 | 68.7 | 3 | 42.9 | 208 | 71.7 | 350 | 67.3 | 270 | 70.7 | 80 | 58.0 |
Adenocarcinoma | 142 | 17.4 | 2 | 28.6 | 39 | 13.5 | 101 | 19.4 | 61 | 16.0 | 40 | 29.0 |
Adenosquamous carcinoma | 25 | 3.1 | 0 | 0.0 | 5 | 1.7 | 20 | 3.8 | 14 | 3.7 | 6 | 4.3 |
Small‐cell carcinoma | 23 | 2.8 | 1 | 14.3 | 3 | 1.0 | 19 | 3.7 | 12 | 3.1 | 7 | 5.1 |
Other/unknown | 66 | 8.1 | 1 | 14.3 | 35 | 12.1 | 30 | 5.8 | 25 | 6.5 | 5 | 3.6 |